Updates are available Correction dated 2024-01-25
Click to view Correction: https://doi.org/10.1038/s41587-024-02142-1
-
Authors
Fiumara, Martina http://orcid.org/0009-0007-5934-9273
Ferrari, Samuele http://orcid.org/0000-0003-1122-1231
Omer-Javed, Attya
Beretta, Stefano http://orcid.org/0000-0003-4375-004X
Albano, Luisa http://orcid.org/0000-0002-0013-4741
Canarutto, Daniele http://orcid.org/0000-0001-6999-8479
Varesi, Angelica
Gaddoni, Chiara
Brombin, Chiara
Cugnata, Federica
Zonari, Erika
Naldini, Matteo Maria http://orcid.org/0000-0002-9542-2884
Barcella, Matteo
Gentner, Bernhard
Merelli, Ivan
Naldini, Luigi http://orcid.org/0000-0002-7835-527X
- License Information
-
More Information
Article History
Received: 21 November 2022
Accepted: 26 July 2023
First Online: 7 September 2023
Change Date: 25 January 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41587-024-02142-1
Competing interests
: L.N. is inventor of patents on applications of HSPC gene editing and transplantation, owned and managed by the San Raffaele Scientific Institute and the Telethon Foundation, including on improved gene editing filed together with M.F., S.F., A.O.-J and D.C. L.N. is founder of and quota holder and consultant for GeneSpire and Epsilen Bio/Chroma Medicine. All other authors have no competing interests.
